Overview

A Phase 1/2A Study of Minerval in Adult Patients With Advanced Solid Tumours

Status:
Completed

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

This is a phase 1/2A, open label, non-randomized study in patients with advanced solid tumours including malignant glioma

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Laminar Pharmaceuticals
Lipopharma Therapeutics SL

Collaborators:

Instituto Oncológico IMQ, Clínica IMQ Zorrotzaurre. Bilbao
Northern Institute for Cancer Research, Newcastle
Onkologikoa, San Sebastián.
Royal Marsden NHS Foundation Trust
Specialized Medical Services (SMS)-Oncology BV
Vall d'Hebron Institute of Oncology